<SEC-DOCUMENT>0001209191-24-003091.txt : 20240212
<SEC-HEADER>0001209191-24-003091.hdr.sgml : 20240212
<ACCEPTANCE-DATETIME>20240212161915
ACCESSION NUMBER:		0001209191-24-003091
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220103
FILED AS OF DATE:		20240212
DATE AS OF CHANGE:		20240212

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Hait William
		CENTRAL INDEX KEY:			0001904791
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03215
		FILM NUMBER:		24620208

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLAZA
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>doc3a.xml
<DESCRIPTION>FORM 3/A SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3/A</documentType>

    <periodOfReport>2022-01-03</periodOfReport>

    <dateOfOriginalSubmission>2022-01-13</dateOfOriginalSubmission>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000200406</issuerCik>
        <issuerName>JOHNSON &amp; JOHNSON</issuerName>
        <issuerTradingSymbol>JNJ</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001904791</rptOwnerCik>
            <rptOwnerName>Hait William</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>ONE JOHNSON &amp; JOHNSON PLAZA</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NEW BRUNSWICK</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>08933</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>See Remarks</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>15996</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">This Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on January 13, 2022, as amended by the Form 3/A filed on February 18, 2022 (&quot;Amended Form 3&quot;), which Amended Form 3 inadvertently reported 71,609 shares beneficially owned by the reporting person instead of the 15,996 shares reported herein. This Form 3/A is deemed to update the number of securities reported as beneficially owned in any Forms 4 subsequently filed by the reporting person through the date hereof.</footnote>
    </footnotes>

    <remarks>Title: EVP, Chief External Innovation and Medical Officer</remarks>

    <ownerSignature>
        <signatureName>/s/ Raavi Deol, as attorney-in-fact for William Hait</signatureName>
        <signatureDate>2024-02-12</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
